Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("PESCHEL, C")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 94

  • Page / 4
Export

Selection :

  • and

AUFBAU UND ANWENDUNGSMOEGLICHKEITEN VON CO2-LEISTUNGSLASERGERAETEN. = CONSTRUCTION ET POSSIBILITE D'EMPLOI DES LASERS DE PUISSANCE AU CO2PESCHEL C.1977; FEINGERAETETECHNIK; DTSCH.; DA. 1977; VOL. 26; NO 7; PP. 291-294; ABS. RUSSE ANGL. FR.; BIBL. 6 REF.Article

A Note on a Prehistoric Model of a DugoutPESCHEL, C.International journal of nautical archaeology and underwater exploration. 1985, Vol 14, Num 3, pp 265-267, issn 0305-7445Article

Zu einem Einbaummodell aus Wiesbaden-ErbenheimPESCHEL, C.Germania. 1984, Vol 62, Num 2, pp 433-436Article

Technologische und typologische Untersuchungen an den Knochen- und Geweihgeräten aus der latènezeitlichen Siedlung von Straubing-BajuwarenstrassePESCHEL, C; SPENNEMANN, D. R.Jahresbericht des Historischen Vereins für Straubing und Umgebung. 1985, Vol 87, pp 21-43, issn 0179-5805Article

Anthropologische und archäozoologische Untersuchungen an Knochenresten aus den mittel- und spätlatènezeitlichen Gräbern von Ulversheim, Kr. Mainz-BingenPESCHEL, C; SPENNEMANN, D. R.Archäologisches Korrespondenzblatt. 1986, Vol 16, Num 3, pp 323-332, issn 0342-734XArticle

Zu zwei Knochengeräten aus einer mittelbronzezeitlichen Siedlung bei Nidderau - Heldenbergen, Main - Kinzig - KreisPESCHEL, C; SPENNEMANN, D. R.Archäologisches Korrespondenzblatt. 1985, Vol 15, Num 2, pp 157-161, issn 0342-734XArticle

The low frequency of clinical resistance to PDGFR inhibitors in myeloid neoplasms with abnormalities of PDGFRA might be related to the limited repertoire of possible PDGFRA kinase domain mutations in vitroVON BUBNOFF, N; GORANTLA, S. P; ENGH, R. A et al.Oncogene (Basingstoke). 2011, Vol 30, Num 8, pp 933-943, issn 0950-9232, 11 p.Article

Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancerLORDICK, F; LORENZEN, S; SERONEIT, T et al.British journal of cancer. 2005, Vol 93, Num 2, pp 190-194, issn 0007-0920, 5 p.Article

Cyclin-dependent kinase inhibitor Roscovitine induces apoptosis in chronic lymphocytic leukemia cellsHAHNTOW, I. N; SCHNELLER, F; OELSNER, M et al.Leukemia. 2004, Vol 18, Num 4, pp 747-755, issn 0887-6924, 9 p.Article

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetronGRALLA, R; LICHINITSER, M; VAN DER VEGT, S et al.Annals of oncology. 2003, Vol 14, Num 10, pp 1570-1577, issn 0923-7534, 8 p.Article

Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cellsDECKER, T; SCHNELLER, F; SPARWASSER, T et al.Blood. 2000, Vol 95, Num 3, pp 999-1006, issn 0006-4971Article

Bcr-Abl kinase promotes cell cycle entry of primary myeloid CML cells in the absence of growth factorsJONILET, T; PESCHEL, C; SCHWAB, R et al.British journal of haematology. 1998, Vol 100, Num 2, pp 295-303, issn 0007-1048Article

Effect of interleukin-3 pretreatment on granulocyte/macrophage colony-stimulating factor induced mobilization of circulating haemopoietic progenitor cellsGEISSLER, K; PESCHEL, C; HÖCKER, P et al.British journal of haematology. 1995, Vol 91, Num 2, pp 299-305, issn 0007-1048Article

Expression of receptors for atrial natriuretic peptide on the murine bone marrow-derived stromal cellsAGUI, T; YAMADA, T; LEGROS, G et al.Endocrinology (Philadelphia). 1992, Vol 130, Num 5, pp 2487-2494, issn 0013-7227Article

Progressive preleukemia presenting amegakaryocytic thrombocytopenic prupura: association of the 5q ― syndrome with a decreased megakaryocytic colony formation and a defective production of Meg-CSFGEISSLER, D; THALER, J; KONWALINKA, G et al.Leukemia research. 1987, Vol 11, Num 8, pp 731-737, issn 0145-2126Article

Studies on differentiation of committed hemopoietic progenitor cells with monoclonal antibodies directed against myeloid differentiation antigensPESCHEL, C; KONWALINKA, G; GEISSLER, D et al.Experimental hematology. 1985, Vol 13, Num 11, pp 1211-1216, issn 0301-472XArticle

Studies of myelopoiesis in vitro on blood and bone marrow cells of patients with acute leukemia in long-term remission = Etudes de la myélopoïèse des cellules du sang et de la moelle osseuse in vitro chez les malades atteints de leucémie aiguë en rémission de longue duréePESCHEL, C; KONWALINKA, G; GEISSLER, D et al.Leukemia research. 1983, Vol 7, Num 3, pp 397-406, issn 0145-2126Article

Sorafenib induces cell death in chronic lymphocytic leukemia by translational downregulation of Mcl-1HUBER, S; OELSNER, M; RINGSHAUSEN, I et al.Leukemia. 2011, Vol 25, Num 5, pp 838-847, issn 0887-6924, 10 p.Article

Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer Results of a phase II study in elderly patients or patients with impaired performance statusABBREDERIS, K; LORENZEN, S; FISCHER VON WEIKERSTHAL, L et al.Critical reviews in oncology/hematology. 2008, Vol 66, Num 1, pp 84-90, issn 1040-8428, 7 p.Article

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junctionDANK, M; ZALUSKI, J; BUGAT, R et al.Annals of oncology. 2008, Vol 19, Num 8, pp 1450-1457, issn 0923-7534, 8 p.Article

Mechanisms of apoptosis-induction by rottlerin : therapeutic implications for B-CLLRINGSHAUSEN, I; OELSNER, M; WEICK, K et al.Leukemia. 2006, Vol 20, Num 3, pp 514-520, issn 0887-6924, 7 p.Article

Resistance of Philadelphia-chromosome positive leukemia towards the kinase inhibitor imatinib (STI571, Glivec): a targeted oncoprotein strikes backVON BUBNOFF, N; PESCHEL, C; DUYSTER, J et al.Leukemia. 2003, Vol 17, Num 5, pp 829-838, issn 0887-6924, 10 p.Article

Phosphorylation of tyrosine 393 in the kinase domain of Bcr-Abl influences the sensitivity towards imatinib in vivo : Spotlight on imatinib as a model for signal transduction inhibitorsMIETHING, C; MUGLER, C; GRUNDLER, R et al.Leukemia. 2003, Vol 17, Num 9, pp 1695-1699, issn 0887-6924, 5 p.Article

Characterization of Grb4, an adapter protein interacting with Bcr-AblCOUTINHO, S; JAHN, T; LEWITZKY, M et al.Blood. 2000, Vol 96, Num 2, pp 618-624, issn 0006-4971Article

Interleukins : clinical pharmacology and therapeutic useAULITZKY, W. E; SCHULER, M; PESCHEL, C et al.Drugs (Basel). 1994, Vol 48, Num 5, pp 667-677, issn 0012-6667Article

  • Page / 4